W. L. Gore & Associates received expanded FDA approval, broadening the use of its balloon-expandable stent graft, opening it up for the treatment of complex aortic aneurysms. The Viabahn VBX endoprosthesis was greenlit for use in both … [Read More...] about FDA approves Gore bridging stent graft in complex aortic aneurysms
Main Content
Featured
Today on Medical Tubing & Extrusion
- FDA approves Gore bridging stent graft in complex aortic aneurysms
- J&J delivers Shockwave data sustaining below-the-knee gains for two years
- Endologix is now Rhevera Medical
- Medtronic snags breakthrough designation for below-the-knee drug-coated balloon
- BD’s IV catheters plant in Utah marks 70 years
Medical Tubing & Extrusion

FDA approves Gore bridging stent graft in complex aortic aneurysms
By Conor Hale
W. L. Gore & Associates received expanded FDA approval, broadening the use of its balloon-expandable stent graft, opening it up for the treatment of complex aortic aneurysms. The Viabahn VBX endoprosthesis was greenlit for use in both … [Read More...] about FDA approves Gore bridging stent graft in complex aortic aneurysms

J&J delivers Shockwave data sustaining below-the-knee gains for two years
By Conor Hale
Johnson & Johnson MedTech (NYSE: JNJ) shared extended clinical findings from its Shockwave intravascular lithotripsy system, from a study aimed at clearing calcified vessel blockages below the knee in patients with peripheral artery … [Read More...] about J&J delivers Shockwave data sustaining below-the-knee gains for two years

Endologix is now Rhevera Medical
Endologix, maker of minimally invasive devices to treat vascular diseases, has rebranded as Rhevera Medical. In a news release posted yesterday, the Santa Rosa, California–based company said the name combines "rheo," Greek for flow, and "vera," … [Read More...] about Endologix is now Rhevera Medical

Medtronic snags breakthrough designation for below-the-knee drug-coated balloon
By Conor Hale
Medtronic (NYSE:MDT) has secured a breakthrough designation from the FDA for a version of its drug-coated balloon aimed at unblocking arteries below the knee, following years of development. The In.Pact BTK catheter is slated for an international, … [Read More...] about Medtronic snags breakthrough designation for below-the-knee drug-coated balloon

BD’s IV catheters plant in Utah marks 70 years
By Conor Hale
BD (NYSE:BDX) is celebrating the 70th birthday of its major manufacturing facility in Utah, which the company said produces billions of molded components each year. Located in the town of Sandy just south of Salt Lake City, the site was founded in … [Read More...] about BD’s IV catheters plant in Utah marks 70 years

HighLife raises more than $90M to advance its TMVR system
HighLife (Paris) recently announced it raised €80 million (more than $90 million U.S.) for a U.S. pivotal study and expanded European commercialization of its TMVR system. The successfully completed fundraise, announced Sept. 22, was co-led by … [Read More...] about HighLife raises more than $90M to advance its TMVR system

Convatec launches new hydrophilic option for self-catheterization
By Conor Hale
Convatec is adding to its Cure family of self-administered urinary catheters, with a new model launching in the U.S. and Canada this month. The Cure Aqua is a ready-to-use intermittent catheter featuring a hydrophilic coating that the company says … [Read More...] about Convatec launches new hydrophilic option for self-catheterization






